Pulse Biosciences, Inc. (PLSE) stock
PLSENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$44.84−1.52 (-3.28%)
Close on Nov 17, 2026Market cap $3.20BP/E –Yield –
Pulse Biosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Pulse Biosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$61.10M. For fiscal 2025 it was -$54.12M. The highest annual figure on record is -$3.32M in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$54.12M | – |
| FY2024 | Dec 31, 2024 | -$36.34M | – |
| FY2023 | Dec 31, 2023 | -$33.04M | – |
| FY2022 | Dec 31, 2022 | -$47.01M | – |
| FY2021 | Dec 31, 2021 | -$54.10M | – |
| FY2020 | Dec 31, 2020 | -$35.37M | – |
| FY2019 | Dec 31, 2019 | -$34.19M | – |
| FY2018 | Dec 31, 2018 | -$23.90M | – |
| FY2017 | Dec 31, 2017 | -$11.09M | – |
| FY2016 | Dec 31, 2016 | -$8.05M | – |
| FY2015 | Dec 31, 2015 | -$3.32M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$18.71M | – |
| Q1 FY2026 | Mar 31, 2026 | -$14.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$14.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$13.04M | – |
| Q2 FY2025 | Jun 30, 2025 | -$12.81M | – |
| Q1 FY2025 | Mar 31, 2025 | -$13.52M | – |
| Q4 FY2024 | Dec 31, 2024 | -$9.14M | – |
| Q3 FY2024 | Sep 30, 2024 | -$9.02M | – |
| Q2 FY2024 | Jun 30, 2024 | -$8.40M | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.78M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$10.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$9.20M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.57M | – |
| Q4 FY2022 | Dec 31, 2022 | -$7.97M | – |
| Q3 FY2022 | Sep 30, 2022 | -$10.63M | – |
| Q2 FY2022 | Jun 30, 2022 | -$12.82M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.59M | – |
| Q4 FY2021 | Dec 31, 2021 | -$12.69M | – |
| Q3 FY2021 | Sep 30, 2021 | -$13.35M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.37M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.69M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.26M | – |
| Q3 FY2020 | Sep 30, 2020 | -$8.55M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.94M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.62M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.20M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.97M | – |
| Q2 FY2019 | Jun 30, 2019 | -$9.69M | – |
| Q1 FY2019 | Mar 31, 2019 | -$7.33M | – |
| Q4 FY2018 | Dec 31, 2018 | -$6.31M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.85M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.72M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.02M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.96M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.42M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.21M | – |
| Q1 FY2017 | Mar 31, 2017 | -$2.50M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.32M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.98M | – |
See a number that looks wrong?